Search Results: BRCA

Prostate cancer deaths double in men with BRCA2

Men with prostate cancer caused by a faulty BRCA2 gene are more than twice as likely to die from the disease than those carrying the faulty BRCA1 gene - reveals a study published in the British Journal of Cancer* today (Tuesday). Men with prostate cancer caused by a faulty BRCA2 gene are more than twice as likely to die from the disease than those carrying the faulty BRCA1 gene - reveals a study published in the British Journal of Cancer* today (Tuesday).

24 June 2008

Cancer Research UK scientists help narrow the search for BRCA1 carriers

Cancer Research UK scientists have identified a new test which may help narrow the search for breast cancer patients likely to carry the faulty BRCA1 gene. Cancer Research UK scientists have identified a new test which may help narrow the search for breast cancer patients likely to carry the faulty BRCA1 gene.

9 August 2005

Scientists uncover how BRCA2 regulates DNA repair

Cancer Research UK scientists have discovered a `molecular switchї that controls an essential DNA repair process, a study published in Nature1 reveals today. Cancer Research UK scientists have discovered a `molecular switchї that controls an essential DNA repair process, a study published in Nature1 reveals today.

30 March 2005

Charity to make breast cancer (BRCA2) gene freely available across Europe

Cancer Research UK today secured a Europe-wide patent on the hereditary breast cancer gene BRCA2, in a move that will be welcomed by scientists across the continent. Cancer Research UK today secured a Europe-wide patent on the hereditary breast cancer gene BRCA2, in a move that will be welcomed by scientists across the continent.

11 February 2004

• Health & Medicine

BRCA1 gene points way to targeting breast cancer treatment

Testing tumours for the breast cancer gene BRCA1 could be a powerful way of predicting how patients will respond to chemotherapy, scientists from Breast Cancer Campaign and Cancer Research UK report. Testing tumours for the breast cancer gene BRCA1 could be a powerful way of predicting how patients will respond to chemotherapy, scientists from Breast Cancer Campaign and Cancer Research UK report.

25 September 2003

How mutant BRCA2 causes cancer

Scientists believe they have uncovered one of the cancer-causing secrets of the breast cancer gene BRCA2. Scientists believe they have uncovered one of the cancer-causing secrets of the breast cancer gene BRCA2.

20 November 2002

• Personal Stories

“Do whatever you can, I need to live - I have my little girl”: Lina's story

Lina tells the story of how a newly available targeted drug helped slow down the growth of faulty BRCA-driven cancer in her body, giving her more time to spend with her loved ones. Lina tells the story of how a newly available targeted drug helped slow down the growth of faulty BRCA-driven cancer in her body, giving her more time to spend with her loved ones.

28 October 2024

• Health & Medicine

Olaparib approved for 800 prostate and breast cancer patients in England

Olaparib, a targeted cancer drug discovered and developed with our funding, has been approved for hundreds of patients with certain breast and prostate cancers in England.  Olaparib, a targeted cancer drug discovered and developed with our funding, has been approved for hundreds of patients with certain breast and prostate cancers in England. 

11 April 2023

• Health & Medicine

Better together: improving brain tumour treatment

We've helped double brain tumour survival over the past 40 years. Now, researchers are combining some of our most successful drugs, temozolomide and PARP inhibitors, to make glioblastoma treatment more effective. We've helped double brain tumour survival over the past 40 years. Now, researchers are combining some of our most successful drugs, temozolomide and PARP inhibitors, to make glioblastoma treatment more effective.

13 February 2023